Genmab — September 2018

[E_L]

New Ph2 trial: A Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen (innovaTV 208) https://www.clinicaltrials.gov/ct2/show/NCT03657043?term=NCT03657043&rank=1

[JKY_VH]

Hej Helge, deltager du også på investordagen i Kolding den 27.11?

[Helge_LarsenPI-redaktør]

De gør jeg med min bog som udkommer i september/oktober.

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[E_L]

nice find. Seems they are even a bit behind with their press release, as clinicaltrials was set to 'active not recruiting' a month ago https://www.clinicaltrials.gov/ct2/history/NCT03298867?A=9&B=10&C=merged

[JKY_VH]

Spændende Helge, så kan det være vi ses;-)

[E_L]

would be something if we would actually end up making money on this, and Ofa in MS, both in different indications as originally thought..

[Sukkeralf]

Likewise with Humax-inflam/Humax-IL8 although a very long way for that

[Plimsoller]

God morgen

[bibob]

God morgen.

[Helge_LarsenPI-redaktør]

God morgen.

[polle1]

God morgen

[henrik48]

God morgen

[Parasitism]

God morgen

[Sukkeralf]

Bliver lidt interessant at se hvad Aduro kan med deres APRIL inhibitor

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[Sukkeralf]

Man kunne jo overveje at købe lidt ind her - markedet er bare generelt lidt træls for
tiden

[Bulder]

Gad vist om den kunne kombineres med dara, som jo også har en vis effekt på Tregs og deres immunosuppressive rolle.

[Zyrlex]

I am a bit worried that MAIA-data will be postponed. Also, there´s the midterm election in the US, that possibly could be at trigger for an increased downside for the stockmarket in general....any comments?

[kkjoel]

Don't worry.